Medical Breakthrough
6 articles
New Antibody Fab5 Targets Gammaherpesvirus gB Broadly
On December 16, 2025, a groundbreaking study revealed Fab5, an antibody capable of protecting mice, non-human primates, and humanized mice from multiple deadly gammaherpesviruses.
Boehringer Ingelheim drug slashes liver and belly fat
In Phase 3 trials, Boehringer Ingelheim's experimental obesity drug, survodutide, helped recipients shed up to 17% of their body weight over 76 weeks, crucially preserving muscle mass.
Retatrutide's Triple Hormone Action Aims to Revolutionize Obesity Treatment
Patients on the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks in the latest study, a result mirroring bariatric surgery, according to the South Florida Reporter
Bepirovirsen data shows functional cure in 19% of hepatitis B patients
An experimental hepatitis B treatment achieved a 'functional cure' in nearly 1 in 5 patients during its pivotal Phase 3 studies, a significant stride against a chronic viral infection that afflicts mi
Stem cell heart patch increases heart wall thickness in patients
In a small clinical trial, patients with advanced heart failure who received a stem cell-based heart patch saw their heart wall thickness increase by 4.
New drug Bepirovirsen functionally cures hepatitis B in some patients
In two late-stage clinical trials, GSK's experimental drug Bepirovirsen achieved a functional cure for 19% of patients with chronic hepatitis B, a disease that has long resisted effective treatment.